Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E[S]

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E[S]

Cholesteryl ester transfer protein (CETP) mediates the transfer of HDL cholesteryl esters for triglyceride (TG) in VLDL/LDL. CETP inhibition, with anacetrapib, increases HDL-cholesterol, reduces LDL-cholesterol, and lowers TG levels. This study describes the mechanisms responsible for TG lowering by...

Full description

Bibliographic Details
Main Authors:	John S. Millar, Michael E. Lassman, Tiffany Thomas, Rajasekhar Ramakrishnan, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Soumia Aoujil, Taylor Standiford, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader, Gissette Reyes-Soffer
Format:	Article
Language:	English
Published:	Elsevier 2017-06-01
Series:	Journal of Lipid Research
Subjects:	lipoprotein metabolism plasma lipid transfer proteins drug therapy kinetics statins cholesteryl ester transfer protein
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520310130

Similar Items

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
by: Theodosios D. Filippatos, et al.
Published: (2017-09-01)

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
by: Ronald M. Krauss, et al.
Published: (2012-03-01)

Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys
by: Mathieu R. Brodeur, et al.
Published: (2017-07-01)

Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux[S]
by: David G. McLaren, et al.
Published: (2016-03-01)

CETP expression reverses the reconstituted HDL-induced increase in VLDL
by: Yanan Wang, et al.
Published: (2011-08-01)

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]
by: Sam J.L. van der Tuin, et al.
Published: (2015-11-01)

Modification of CETP function by changing its substrate preference: a new paradigm for CETP drug design
by: Richard E. Morton, et al.
Published: (2015-03-01)

Human plasma CETP deficiency: identification of a novel mutation in exon 9 of the CETP gene in a Caucasian subject from North America
by: Evelyn M. Teh, et al.
Published: (1998-02-01)

Association between cholestryl ester transfer protein D442G polymorphism on serum lipid levels and CETP activity in hypercholesterolemic patients
by: Barkhordari Asgar, et al.
Published: (2012-03-01)

A CYP7A promoter binding factor site and Alu repeat in the distal promoter region are implicated in regulation of human CETP gene expression
by: Wilfried Le Goff, et al.
Published: (2003-05-01)

A novel swine model for evaluation of dyslipidemia and atherosclerosis induced by human CETP overexpression
by: Tao Chen, et al.
Published: (2017-09-01)

Defective triglyceride biosynthesis in CETP-deficient SW872 cells
by: Diane J. Greene, et al.
Published: (2015-09-01)

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
by: Mark P. Metzinger, et al.
Published: (2020-12-01)

CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL
by: Richard E. Morton, et al.
Published: (2003-12-01)

CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice
by: Silvia Bijland, et al.
Published: (2010-01-01)

Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters
by: Jose Castro-Perez, et al.
Published: (2011-11-01)

A review of CETP and its relation to atherosclerosis
by: Greetje J. de Grooth, et al.
Published: (2004-11-01)

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes1
by: David Masson, et al.
Published: (2006-02-01)

Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
by: Lee A. Morehouse, et al.
Published: (2007-07-01)

In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption
by: Sheng-Ping Wang, et al.
Published: (2013-10-01)

High-density genotyping and functional SNP localization in the CETP genes⃞
by: John F. Thompson, et al.
Published: (2007-02-01)

A Molecular and Biochemical Study for Cholesteryl Ester Transfer Protein (CETP) Taq1B in Iraqi Patients with Hyperlipidemia
by: Alkhafajy et al.
Published: (2019-09-01)

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
by: S. Matthijs Boekholdt, et al.
Published: (2003-06-01)

CETP inhibitor evacetrapib enters mouse brain tissue
by: Jasmine Phénix, et al.
Published: (2023-07-01)

Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease[S]
by: Xavier Pillois, et al.
Published: (2012-06-01)

Synthetic LXR agonists increase LDL in CETP species
by: Pieter H.E. Groot, et al.
Published: (2005-10-01)

Expression of CETP and of splice variants induces the same level of ER stress despite secretion efficiency differences
by: Maruja E. Lira, et al.
Published: (2008-09-01)

Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
by: Mathieu R. Brodeur, et al.
Published: (2023-01-01)

TaqI B1/B2 and -629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS)
by: Maryam S Daneshpour, et al.
Published: (2007-01-01)

Establishment of cetp-/- model and liver transcriptomics study in zebrafish
by: FENG Dong-ping, SHANG Han-qiao, YANG Hang, ZHANG Hu-jun, ZHANG Ting, YANG Meng-xi, TU Qiang, REN Jing-yi
Published: (2020-07-01)

Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state
by: Maryse Guerin, et al.
Published: (2002-10-01)

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
by: Julia Nowowiejska, et al.
Published: (2022-04-01)

Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects
by: Richard E. Morton, et al.
Published: (2008-01-01)

Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones
by: Melissa N. Martinez, et al.
Published: (2012-03-01)

The lipid transfer properties of CETP define the concentration and composition of plasma lipoproteins[S]
by: Richard E. Morton, et al.
Published: (2020-08-01)

The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis
by: Parra Eliane, et al.
Published: (2012-10-01)

Association of -971 G/A cholesteryl-ester transfer protein gene polymorphism with lipid profile in primary hyperlipidemia
by: Hassanzadeh T, et al.
Published: (2012-10-01)

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG
by: Iris J.A.M. Jonkers, et al.
Published: (2003-08-01)

Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease
by: Carolina H. M Azevedo, et al.
Published: (2011-01-01)

Epitope mapping for the anti-rabbit cholesteryl ester transfer protein monoclonal antibody that selectively inhibits triglyceride transfer
by: Kazunori Saito, et al.
Published: (1999-11-01)